Caldwell JR, Ruddy S, Schur PH, Austen KF: Acquired C1 inhibitor deficiency in lymphosarcoma. Clin Immunol Immunopathol. 1972, 1: 39-52. 10.1016/0090-1229(72)90006-2.
Article
Google Scholar
Zingale LC, Castelli R, Zanichelli A, Cicardi M: Acquired deficiency of the inhibitor of the first complement component: presentation, diagnosis, course, and conventional management. Immunol Allergy Clin North Am. 2006, 26: 669-90. 10.1016/j.iac.2006.08.002.
Article
PubMed
Google Scholar
Bygum A: Hereditary angio-oedema in Denmark: a nationwide survey. Br J Dermatol. 2009, 161: 1153-8. 10.1111/j.1365-2133.2009.09366.x.
Article
CAS
PubMed
Google Scholar
Zuraw BL: Clinical practice. Hereditary angioedema. N Engl J Med. 2008, 359: 1027-36. 10.1056/NEJMcp0803977.
Article
CAS
PubMed
Google Scholar
Agostoni A, Aygören-Pürsün E, Binkley KE, Blanch A, Bork K, Bouillet L, Bucher C, Castaldo AJ, Cicardi M, Davis AE, De Carolis C, Drouet C, Duponchel C, Farkas H, Fáy K, Fekete B, Fischer B, Fontana L, Füst G, Giacomelli R, Gröner A, Hack CE, Harmat G, Jakenfelds J, Juers M, Kalmár L, Kaposi PN, Karádi I, Kitzinger A, Kollár T: Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol. 2004, 114: S51-131. 10.1016/j.jaci.2004.06.047.
Article
PubMed
Google Scholar
Nussberger J, Cugno M, Amstutz C, Cicardi M, Pellacani A, Agostoni A: Plasma bradykinin in angio-oedema. Lancet. 1998, 351: 1693-7. 10.1016/S0140-6736(97)09137-X.
Article
CAS
PubMed
Google Scholar
Davis AE: C1 inhibitor and hereditary angioneurotic edema. Annu Rev Immunol. 1988, 6: 595-628. 10.1146/annurev.iy.06.040188.003115.
Article
CAS
PubMed
Google Scholar
Zingale LC, Zanichelli A, Deliliers DL, Rondonotti E, De Franchis R, Cicardi M: Successful resolution of bowel obstruction in a patient with hereditary angioedema. Eur J Gastroenterol Hepatol. 2008, 20: 583-7. 10.1097/MEG.0b013e3282f1c995.
Article
PubMed
Google Scholar
Bouillet-Claveyrolas L, Ponard D, Drouet C, Massot C: Clinical and biological distinctions between type I and type II acquired angioedema. Am J Med. 2003, 115: 420-1. 10.1016/S0002-9343(03)00396-6.
Article
PubMed
Google Scholar
Eck SL, Morse JH, Janssen DA, Emerson SG, Markovitz DM: Angioedema presenting as chronic gastrointestinal symptoms. Am J Gastroenterol. 1993, 88: 436-9.
CAS
PubMed
Google Scholar
Schreiber AD, Zweiman B, Atkins P, Goldwein F, Pietra G, Atkinson B, Abdou NI: Acquired angioedema with lymphoproliferative disorder: association of C1 inhibitor deficiency with cellular abnormality. Blood. 1976, 48: 567-80.
CAS
PubMed
Google Scholar
Hauptmann G, Lang JM, North ML, Oberling F, Mayer G, Lachmann P: Acquired c1-inhibitor deficiencies in lymphoproliferative diseases with serum immunoglobulin abnormalities. A study of three cases. Blut. 1976, 32: 195-206. 10.1007/BF00995913.
Article
CAS
PubMed
Google Scholar
Castelli R, Deliliers DL, Zingale LC, Pogliani EM, Cicardi M: Lymphoproliferative disease and acquired C1 inhibitor deficiency. Haematologica. 2007, 92: 716-8. 10.3324/haematol.10769.
Article
PubMed
Google Scholar
Hauptmann G, Petitjean F, Lang JM, Oberling F: Acquired C1 inhibitor deficiency in a case of lymphosarcoma of the spleen. Reversal of complement abnormalities after splenectomy. Clin Exp Immunol. 1979, 37: 523-31.
PubMed Central
CAS
PubMed
Google Scholar
Levi M, Hack CE, van Oers MH: Rituximab-induced elimination of acquired angioedema due to C1-inhibitor deficiency. Am J Med. 2006, 119: e3-5. 10.1016/j.amjmed.2005.09.018.
Article
PubMed
Google Scholar
Jackson J, Sim RB, Whelan A, Feighery C: An IgG autoantibody which inactivates C1-inhibitor. Nature. 1986, 323: 722-4. 10.1038/323722a0.
Article
CAS
PubMed
Google Scholar
Alsenz J, Bork K, Loos M: Autoantibody-mediated acquired deficiency of C1 inhibitor. N Engl J Med. 1987, 316: 1360-6. 10.1056/NEJM198705283162202.
Article
CAS
PubMed
Google Scholar
Malbran A, Hammer CH, Frank MM, Fries LF: Acquired angioedema: observations on the mechanism of action of autoantibodies directed against C1 esterase inhibitor. J Allergy Clin Immunol. 1988, 81: 1199-204. 10.1016/0091-6749(88)90891-3.
Article
CAS
PubMed
Google Scholar
Mandle R, Baron C, Roux E, Sundel R, Gelfand J, Aulak K, Davis AE, Rosen FS, Bing DH: Acquired C1 inhibitor deficiency as a result of an autoantibody to the reactive center region of C1 inhibitor. J Immunol. 1994, 152: 4680-5.
CAS
PubMed
Google Scholar
Alsenz J, Loos M: The acquired C1-INH deficiencies with autoantibodies (AAE type II). Behring Inst Mitt. 1989, 165-72. 84
Cicardi M, Beretta A, Colombo M, Gioffre D, Cugno M, Agostoni A: Relevance of lymphoproliferative disorders and of anti-C1 inhibitor autoantibodies in acquired angio-oedema. Clin Exp Immunol. 1996, 106: 475-80. 10.1046/j.1365-2249.1996.d01-866.x.
Article
PubMed Central
CAS
PubMed
Google Scholar
Cugno M, Castelli R, Cicardi M: Angioedema due to acquired C1-inhibitor deficiency: a bridging condition between autoimmunity and lymphoproliferation. Autoimmun Rev. 2008, 8: 156-9. 10.1016/j.autrev.2008.05.003.
Article
CAS
PubMed
Google Scholar
Nettis E, Colanardi MC, Loria MP, Vacca A: Acquired C1-inhibitor deficiency in a patient with systemic lupus erythematosus: a case report and review of the literature. Eur J Clin Invest. 2005, 35: 781-4. 10.1111/j.1365-2362.2005.01571.x.
Article
CAS
PubMed
Google Scholar
Nagy L, Hannema A, Swaak A: Acquired C1 inhibitor deficiency associated with systemic lupus erythematosus, secondary antiphospholipid syndrome and IgM monoclonal paraproteinaemia. Clin Rheumatol. 1999, 18: 56-8. 10.1007/s100670050054.
Article
CAS
PubMed
Google Scholar
Ochonisky S, Intrator L, Wechsler J, Revuz J, Bagot M: Acquired C1 inhibitor deficiency revealing systemic lupus erythematosus. Dermatology. 1993, 186: 261-3. 10.1159/000247366.
Article
CAS
PubMed
Google Scholar
Nakamura S, Yoshinari M, Saku Y, Hirakawa K, Miishima C, Murai K, Tokiyama K, Fujishima M: Acquired C1 inhibitor deficiency associated with systemic lupus erythematosus affecting the central nervous system. Ann Rheum Dis. 1991, 50: 713-6. 10.1136/ard.50.10.713.
Article
PubMed Central
CAS
PubMed
Google Scholar
Wasserfallen JB, Spaeth P, Guillou L, Pecoud AR: Acquired deficiency in C1-inhibitor associated with signet ring cell gastric adenocarcinoma: a probable connection of antitumor-associated antibodies, hemolytic anemia, and complement turnover. J Allergy Clin Immunol. 1995, 95: 124-31. 10.1016/S0091-6749(95)70160-5.
Article
CAS
PubMed
Google Scholar
Cohen SH, Koethe SM, Kozin F, Rodey G, Arkins JA, Fink JN: Acquired angioedema associated with rectal carcinoma and its response to danazol therapy. Acquired angioedema treated with danazol. J Allergy Clin Immunol. 1978, 62: 217-21. 10.1016/0091-6749(78)90210-5.
Article
CAS
PubMed
Google Scholar
Varvarovska J, Sykora J, Stozicky F, Chytra I: Acquired angioedema and Helicobacter pylori infection in a child. Eur J Pediatr. 2003, 162: 707-9. 10.1007/s00431-003-1250-7.
Article
PubMed
Google Scholar
Reche M, Caballero T, López-Trascasa M, Arribas JR, López Serrano MC: Angioedema and transient acquired C1 inhibitor functional deficiency in HIV infection: case report. Aids. 2002, 16: 1561-10.1097/00002030-200207260-00016.
Article
CAS
PubMed
Google Scholar
Farkas H, Gyeney L, Majthenyi P, Fust G, Varga L: Angioedema due to acquired C1-esterase inhibitor deficiency in a patient with Helicobacter pylori infection. Z Gastroenterol. 1999, 37: 513-8.
CAS
PubMed
Google Scholar
Minh D, Czink E, Fust G, Hollan SR: Acquired C1-esterase inhibitor deficiency and recurrent herpes infection in a patient with chronic lymphocytic leukemia. Diagn Immunol. 1983, 1: 68-71.
CAS
PubMed
Google Scholar
Cicardi M, Frangi D, Bergamaschini L, Gardinali M, Sacchi G, Agostoni A: Acquired C1 inhibitor deficiency with angioedema symptoms in a patient infected with Echinococcus granulosus. Complement. 1985, 2: 133-9.
CAS
PubMed
Google Scholar
Wagenaar-Bos IG, Drouet C, Aygören-Pursun E, Bork K, Bucher C, Bygum A, Farkas H, Fust G, Gregorek H, Hack CE, Hickey A, Joller-Jemelka HI, Kapusta M, Kreuz W, Longhurst H, Lopez-Trascasa M, Madalinski K, Naskalski J, Nieuwenhuys E, Ponard D, Truedsson L, Varga L, Nielsen EW, Wagner E, Zingale L, Cicardi M, van Ham SM: Functional C1-inhibitor diagnostics in hereditary angioedema: assay evaluation and recommendations. J Immunol Methods. 2008, 338: 14-20. 10.1016/j.jim.2008.06.004.
Article
CAS
PubMed
Google Scholar
Bork K, Barnstedt SE: Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema. Arch Intern Med. 2001, 161: 714-8. 10.1001/archinte.161.5.714.
Article
CAS
PubMed
Google Scholar
Frank MM, Jiang H: New therapies for hereditary angioedema: disease outlook changes dramatically. J Allergy Clin Immunol. 2008, 121: 272-80. 10.1016/j.jaci.2007.11.019.
Article
PubMed
Google Scholar
Gelfand JA, Sherins RJ, Alling DW, Frank MM: Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities. N Engl J Med. 1976, 295: 1444-8. 10.1056/NEJM197612232952602.
Article
CAS
PubMed
Google Scholar
Melamed J, Alper CA, Cicardi M, Rosen FS: The metabolism of C1 inhibitor and C1q in patients with acquired C1- inhibitor deficiency. J Allergy Clin Immunol. 1986, 77: 322-6. 10.1016/S0091-6749(86)80111-7.
Article
CAS
PubMed
Google Scholar
Frank MM, Sergent JS, Kane MA, Alling DW: Epsilon aminocaproic acid therapy of hereditary angioneurotic edema. A double-blind study. N Engl J Med. 1972, 286: 808-12. 10.1056/NEJM197204132861503.
Article
CAS
PubMed
Google Scholar
Sheffer AL, Austen KF, Rosen FS: Tranexamic acid therapy in hereditary angioneurotic edema. N Engl J Med. 1972, 287: 452-4. 10.1056/NEJM197208312870907.
Article
CAS
PubMed
Google Scholar
Donaldson VH, Rosen FS, Bing DH: Role of the second component of complement (C2) and plasmin in kinin release in hereditary angioneurotic edema (H.A.N.E.) plasma. Trans Assoc Am Physicians. 1977, 90: 174-83.
CAS
PubMed
Google Scholar
Cugno M, Hack CE, de Boer JP, Eerenberg AJ, Agostoni A, Cicardi M: Generation of plasmin during acute attacks of hereditary angioedema. J Lab Clin Med. 1993, 121: 38-43.
CAS
PubMed
Google Scholar
Cugno M, Cicardi M, Agostoni A: Activation of the contact system and fibrinolysis in autoimmune acquired angioedema: a rationale for prophylactic use of tranexamic acid. J Allergy Clin Immunol. 1994, 93: 870-6. 10.1016/0091-6749(94)90380-8.
Article
CAS
PubMed
Google Scholar
Cugno M, Cicardi M, Coppola R, Agostoni A: Activation of factor XII and cleavage of high molecular weight kininogen during acute attacks in hereditary and acquired C1-inhibitor deficiencies. Immunopharmacology. 1996, 33: 361-4. 10.1016/0162-3109(96)00086-0.
Article
CAS
PubMed
Google Scholar
Cugno M, Cicardi M, Bottasso B, Coppola R, Paonessa R, Mannucci PM, Agostoni A: Activation of the coagulation cascade in C1-inhibitor deficiencies. Blood. 1997, 89: 3213-8.
CAS
PubMed
Google Scholar
Levi M, Choi G, Picavet C, Hack C: Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiency. J Allergy Clin Immunol. 2006, 117: 904-8. 10.1016/j.jaci.2006.01.002.
Article
CAS
PubMed
Google Scholar
Bork K, Witzke G: Long-term prophylaxis with C1-inhibitor (C1 INH) concentrate in patients with recurrent angioedema caused by hereditary and acquired C1-inhibitor deficiency. J Allergy Clin Immunol. 1989, 83: 677-82. 10.1016/0091-6749(89)90082-1.
Article
CAS
PubMed
Google Scholar
Martinez-Saguer I, Rusicke E, Aygören-Pürsün E, von Hentig N, Klingebiel T, Kreuz W: Pharmacokinetic analysis of human plasma-derived pasteurized C1-inhibitor concentrate in adults and children with hereditary angioedema: a prospective study. Transfusion. 2010, 50: 354-60. 10.1111/j.1537-2995.2009.02394.x.
Article
CAS
PubMed
Google Scholar